The Korean journal of internal medicine

  • 제29권5호
  • /
  • Pages.571-573
  • /
  • 2014
  • /
  • 1226-3303(pISSN)
  • /
  • 2005-6648(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

Adverse effects of long-term amiodarone therapy

  • Park, Hyoung-Seob (Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center) ;
  • Kim, Yoon-Nyun (Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center)
  • 투고 : 2014.07.28
  • 심사 : 2014.07.31
  • 발행 : 2014.09.01
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Kim HL, Seo JB, Chung WY, Kim SH, Kim MA, Zo JH. The incidence and predictors of overall adverse effects caused by low dose amiodarone in real-world clinical practice. Korean J Intern Med 2014;29:588-596. https://doi.org/10.3904/kjim.2014.29.5.588
  2. Goldschlager N, Epstein AE, Naccarelli GV, et al. A practical guide for clinicians who treat patients with amiodarone: 2007. Heart Rhythm 2007;4:1250-1259. https://doi.org/10.1016/j.hrthm.2007.07.020
  3. Vorperian VR, Havighurst TC, Miller S, January CT. Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol 1997;30:791-798. https://doi.org/10.1016/S0735-1097(97)00220-9
  4. Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet 1997;350:1417-1424. https://doi.org/10.1016/S0140-6736(97)05281-1
  5. Dusman RE, Stanton MS, Miles WM, et al. Clinical features of amiodarone-induced pulmonary toxicity. Circulation 1990;82:51-59. https://doi.org/10.1161/01.CIR.82.1.51
  6. Basaria S, Cooper DS. Amiodarone and the thyroid. Am J Med 2005;118:706-714. https://doi.org/10.1016/j.amjmed.2004.11.028
  7. Mantyjarvi M, Tuppurainen K, Ikaheimo K. Ocular side effects of amiodarone. Surv Ophthalmol 1998;42:360-366. https://doi.org/10.1016/S0039-6257(97)00118-5
  8. Cho YK, Kim YN, Han SW, et al. Clinical reviews about overall incidence of adverse effects in amiodarone treatment. Keimyung Med J 2007;26:87-95.
  9. Hohnloser SH, Crijns HJ, van Eickels M, et al. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009;360:668-678. https://doi.org/10.1056/NEJMoa0803778
  10. Le Heuzey JY, De Ferrari GM, Radzik D, Santini M, Zhu J, Davy JM. A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study. J Cardiovasc Electrophysiol 2010;21:597-605. https://doi.org/10.1111/j.1540-8167.2010.01764.x

피인용 문헌

  1. Chinese herbal medicine for patients with atrial fibrillation: protocol for a systematic review and meta-analysis vol.96, pp.50, 2014, https://doi.org/10.1097/md.0000000000009228
  2. Insulin-like growth factor-1 activates PI3K/Akt signalling to protect human retinal pigment epithelial cells from amiodarone-induced oxidative injury : IGF-1 prevents amiodarone-induced oxidative inju vol.175, pp.1, 2014, https://doi.org/10.1111/bph.14078
  3. Atrial Arrhythmias in a Patient Presenting With Coronavirus Disease-2019 (COVID-19) Infection vol.8, pp.None, 2014, https://doi.org/10.1177/2324709620925571
  4. Long-term Outcome of Pulmonary Vein Isolation Versus Amiodarone Therapy in Patients with Coexistent Persistent AF and Congestive Heart Failure vol.6, pp.None, 2014, https://doi.org/10.15420/cfr.2019.03
  5. Amiodarone-induced sudden onset of polymorphic ventricular tachycardia following dislodgement of a temporary pacemaker: a case report vol.36, pp.6, 2014, https://doi.org/10.1007/s40267-020-00729-7
  6. Levetiracetam for the treatment of myoclonic neurotoxicity induced by amiodarone vol.6, pp.8, 2014, https://doi.org/10.1016/j.hrcr.2020.04.010
  7. Amiodarone, Unlike Dronedarone, Activates Inflammasomes via Its Reactive Metabolites: Implications for Amiodarone Adverse Reactions vol.34, pp.8, 2014, https://doi.org/10.1021/acs.chemrestox.1c00127
  8. Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning vol.15, pp.1, 2022, https://doi.org/10.3390/ph15010031